Objective: Increasing evidence point to the role of the adipose tissue on the insulin resistance associated with reduced fetal growth. Since adiponectin, exclusively produced by the adipose tissue, exerts an important insulin-sensitizing activity, it appears critical to investigate the effect of being born small for gestational age (SGA) on adiponectin production in adulthood and its relationship with insulin sensitivity. Subjects and methods: Serum adiponectin concentrations were measured in 486 young adults born SGA, precisely selected on birth data, who were compared to 573 age-matched subjects born appropriate for gestational age (AGA). The relationship between serum adiponectin levels and insulin-resistance indices measured under OGTT were tested and compared between the two groups.
Introduction
The association between reduced fetal growth and the metabolic syndrome (dyslipidemia, hypertension and cardiovascular diseases, insulin resistance and type 2 diabetes) has been substantially documented in various populations. [1] [2] [3] Similar to what originally described in Humans, these metabolic complications seem to cluster with insulin resistance detectable as soon as the prepubertal period in children born small for gestational age (SGA). [4] [5] [6] The role of the adipose tissue in the pathophysiology of insulin resistance has been clearly demonstrated. 7, 8 In addition to the contribution of lipolysis regulation, recent studies have pointed to the role of the endocrine functions of the adipose tissue on the control of insulin sensitivity. [9] [10] [11] Among these hormones, adiponectin that is exclusively produced by the adipose tissue exerts an important insulinsensitizing effect. 12, 13 Increasing evidence strongly suggest that adipose tissue plays a critical role on the insulin resistance associated with reduced fetal growth. Subjects born SGA display a very peculiar development pattern of the adipose tissue. Dramatically reduced at birth, adiposity undergoes a catch-up growth process during infancy and childhood that has been shown to favor insulin resistance in adulthood. 14, 15 Moreover, we have shown that this peculiar development of adiposity is associated with abnormal lipolysis regulation and leptin production in young adults born SGA, both able to play a deleterious role in the control of insulin sensitivity in this population. 16, 17 Investigating the effect of being born SGA on adiponectin production in adulthood appears therefore critical to better understand the contribution of the adipose tissue on the insulin resistance associated with reduced fetal growth. To achieve this goal, serum adiponectin concentrations were measured in a cohort of young adults born SGA, precisely selected on birth data, who were compared to age-matched subjects born appropriate for gestational age (AGA). Moreover, the relationship between serum adiponectin levels and insulin-sensitivity indices measured under OGTT were compared between the two groups.
Subjects and methods

Subjects
The study population was made of young healthy volunteers born either small or AGA. They were randomly selected on birth data from a population-based registry of the metropolitan area of the city of Haguenau in France. This registry included information about all pregnancies and deliveries occurring in this maternity unit from 1971 to 1985 (n ¼ 27 366), and the degree of ascertainment of the registry was more than 80%. 18 In this region (north east France), non-Caucasian subjects represent less than 0.1%. The SGA group included singleton subjects born between 32 and 42 weeks of gestation with birth weight o10th percentile for gender and gestational age according to the local growth standard curves deriving from the registry. The AGA group was made of singleton subjects, born between 32 and 42 weeks of gestation with birth size between the 25th and the 75th percentiles, who were the first babies in the registry born immediately after a subject born SGA. Clinical characteristics of the two groups at birth are given in Table 1a . Mean gestational ages were similar in both groups and gender distribution did not significantly differ between the SGA and AGA groups. According to the selection criteria, subjects born SGA were significantly lighter, shorter and thinner at birth than subjects born AGA when corrected for gestational age and gender.
Study design
Subjects who agreed to participate attended a medical visit at the Haguenau Hospital. Information about medical history was recorded using a standardized questionnaire. Body weight was measured with a portable scale and height with a wall-mounted stadiometer. Weight for height was assessed as body mass index (BMI: kg/m 2 ). Waist circumference was measured at the level of the umbilicus and hip circumference at the level of the greater trochanter. Blood samples were collected after an overnight fast for measurement of plasma glucose and serum insulin and adiponectin concentrations. A 75 g oral glucose tolerance test was performed and plasma glucose and serum insulin concentrations were measured 30 and 120 min after the glucose load.
The study protocol was reviewed and approved by the ethical committee of the University of Paris-St Louis and all subjects gave written informed consent.
Laboratory procedures
Plasma glucose concentrations were measured with an enzymatic method.
Serum insulin concentrations were measured using a double-antibody radio immuno assay (ERIA Diagnostics Pasteur, Paris, France). Crossreactivity with proinsulin and derived metabolites was less than 1%. Assay sensitivity was 1.2 pmol/l and intra-and interassays coefficients of variations were 3.8 and 8% at 48 pmol/, and 2.4 and 4.8% at 300 pmol/l. Serum adiponectin was measured using a specific radioimmunoassay (Linco-Research, St Charles, MO, USA). The sensitivity of the assay was 1.0 mg/ml with intra-and interassay coefficient of variation (CVs) of 1.8-6.2 and 6.9-9.2%, respectively.
Statistical analysis
Statistical analyses were performed using the SAS statistical package. (SAS 8.2, SAS Institute, Meylan, France). Serum insulin and adiponectin concentrations, insulin area under the curve and fasting insulin-to-glucose ratio were log transformed to remove skewness.
The association between SGA/AGA status and biological and clinical parameters was tested using a w 2 test for qualitative variables. Multivariate analyses were performed using stepwise regression models. Anthropometric parameters were analyzed after adjustment for gender and age. Insulin resistance indices (fasting insulin, insulin area under the curve and fasting insulin-to-glucose ratio) were analyzed after adjustment for gender, age, BMI, waist-to-hip ratio, smoking, oral contraception and family history of type 2 diabetes. Serum adiponectin concentrations were analyzed after adjustment for gender, BMI, waist-to-hip ratio, smoking, oral contraception. The relationship between insulin resistance and adiponectin concentrations was tested in the two groups divided Results are expressed as mean (s.d.). Anthropometric parameters were compared after adjustment for gender and gestational age at birth and after adjustment for gender and current age at the time of the study.
Serum adiponectin levels in subjects born SGA D Jaquet et al into quartiles of adiponectin concentrations using a GLM procedure with fasting insulinemia and insulin-to-glucose ratio as dependent variables and quartiles of adiponectin, age, gender, BMI, familial history of type 2 diabetes, smoking and oral contraception as covariates.
Effects of adiposity at birth and catch-up in adiposity were studied after Z-score transformation of the BMI values. At birth, Z-scores were derived from the local growth standards in the registry of Haguenau (n ¼ 27 366), corrected for gender and gestational age. At the time of the study, Z-scores were derived from the AGA group as the reference group (n ¼ 573) and corrected for gender. The magnitude of catch-up growth in BMI was quantified by the difference between adult and birth values expressed in Z-scores. Analyses of the independent effects of BMI at birth and catch-up in adiposity were conducted using GLM procedures after adjustment for gender, current age, current BMI, smoking, oral contraception, family history of metabolic diseases, for the insulinresistance indices and after adjustment for current BMI, waist-to-hip ratio, gender, oral contraception and fasting insulinemia for serum adiponectin.
Statistical significance was taken at Pp0.05.
Results
Clinical and metabolic characteristics
Clinical characteristics of the two groups at the time of the study are summarized in Table 1b . The mean age of the two groups was 22 years. Gender distribution was comparable in the two groups. Subjects born SGA remained significantly shorter and lighter as young adults, but the mean BMI and the mean waist-to-hip ratio did not significantly differ between the two groups. Family history of type 2 diabetes was similar in both groups (4 vs 4%, P ¼ 0.96). Smoking habit was observed in 34% of the SGA group and 32% of the AGA group (0.35). Frequency of oral contraception was similar in the SGA and AGA women (58 vs 63%, P ¼ 0.26).
Glucose tolerance and insulin-resistance indices are summarized in Table 2 . Fasting plasma glucose did not significantly differ between the two groups, but subjects born SGA demonstrated a significantly higher 2-h-postload blood glucose level. Accordingly, the frequency of impaired glucose tolerance was 2.7-fold higher in this group in comparison to the AGA group according to the WHO-99 criteria. 19 Insulin-resistance indices (fasting insulinemia and insulin-to-glucose ratio, insulin area under the curve) derived from OGTT were significantly higher in the SGA group in comparison to the AGA group.
Serum adiponectin level and its determinants
In the study population as a whole, serum adiponectin levels were negatively correlated to the degree of adiposity assessed by BMI (r ¼ À0.10, P ¼ 0.0008), and this negative relationship was even more pronounced with the waist-to-hip ratio (r ¼ À0.34, Po0.0001). Mean serum adiponectin levels were significantly higher in females than in males (11.0 þ 5.7 vs 14.876.9 mg/ml, P ¼ 0.0001), but were significantly reduced by oral contraception (P ¼ 0.005). The antagonistic effect of smoking on serum adiponectin levels did not reach statistical significance (P ¼ 0.06) in the study population. The mean value of serum adiponectin levels was significantly reduced in the SGA group in comparison to the AGA group (12.6676.84 vs 13.2376.42 mg/ml, respectively) and the difference was highly significant when adjusted for gender, BMI, waist-to-hip ratio and oral contraception (P ¼ 0.008). No statistical interactions were evidenced between these covariates and the SGA/AGA variable on the mean adiponectin concentrations. Moreover, although subjects born SGA showed a decreased insulin sensitivity in comparison to the AGA group, serum adiponectin concentrations remained significantly lower in the SGA group when insulin-resistance indices were taken into account in addition to the other covariates (Po0.01 when adjusted for fasting insulinemia or insulin-to-glucose ratio, or insulin area under the curve).
Serum adiponectin concentration and insulin sensitivity
Although subjects born SGA showed a decreased insulin sensitivity in comparison to the AGA group, serum adiponectin concentrations remained significantly lower in the SGA group when insulin-resistance indices were taken into account in addition to the other confounding factors (Po0.01 when adjusted for fasting insulinemia or insulinto-glucose ratio, or insulin area under the curve).
In order to evaluate the insulin-sensitizing action of adiponectin in subjects born SGA, we compared the relationship between serum adiponectin levels and insulinresistance indices in both groups. Figure 1 illustrates the relationship between serum adiponectin concentrations being divided in quartiles and fasting insulin-to-glucose ratio in both groups. In the AGA group, fasting insulinto-glucose ratio decreased with the increase of serum adiponectin level and the trend across quartiles was Serum adiponectin levels in subjects born SGA D Jaquet et al significant (P ¼ 0.02). In contrast, in subjects born SGA, the relationship between fasting insulin-to-glucose ratio and serum adiponectin level followed a U-shape across quartiles with increased fasting insulin-to-glucose ratio despite high concentrations of serum adiponectin (P ¼ 0.12). Similar observations were made with the fasting insulin concentrations (AGA group: P ¼ 0.02; SGA group: P ¼ 0.14) and the insulin area under the curve (AGA group: P ¼ 0.04; SGA group: P ¼ 0.25) taken as insulin-resistance indices.
Effect of catch-up growth on serum adiponectin levels and insulin sensitivity in subjects born SGA In subjects born SGA, fasting insulin-to-glucose ratio and insulinemia (r ¼ À0.11, P ¼ 0.008; r ¼ À0.10, P ¼ 0.01, respectively) were inversely related to BMI at birth and positively related to catch-up in BMI, assessed by the magnitude of gain in BMI (Z-score) from birth to adulthood (r ¼ 0.33, P ¼ 0.002; r ¼ 0.34, P ¼ 0.007, respectively). These relationships remained significant when adult BMI was taken into account. In contrast, neither BMI at birth nor catch-up in BMI was significantly associated with serum adiponectin concentrations (r ¼ 0.10, P ¼ 0.54; r ¼ À0.04, P ¼ 0.88).
Discussion
We have demonstrated in the present study that serum adiponectin levels were significantly reduced in subjects born SGA. No significant differences were observed between the SGA and AGA groups in the regulatory effect of the key determinants influencing serum adiponectin levels (BMI, gender or waist-to-hip ratio), but when these determinants were taken into account, serum adiponectin levels remained significantly lower in the SGA group. Moreover, although insulin resistance is known to be associated with lower levels of serum adiponectin, the decreased insulin sensitivity observed in the SGA group did not explain by itself the difference in serum adiponectin levels observed between the two study groups. Hence, these finding suggest that the low serum adiponectin levels observed in subjects born SGA does not reflect difference in the key regulatory factors of adiponectin production but would rather result from reduced fetal growth itself. This observation is in agreement with a previous study reporting that children born SGA had significantly reduced serum adiponectin concentrations in comparison to short children born AGA. 20 Moreover, the same authors have found that catch-up growth negatively influenced serum adiponectin concentrations in children born SGA. 20 Their results would suggest that the mechanism involved in the catch-up growth process observed during childhood affects the hormonal functions of the adipose tissue. By showing that serum adiponectin concentrations remain reduced in subjects born SGA until adulthood, our data suggest that this decrease is not a transitory phenomenon associated with catch-up growth but should rather be considered as a permanent consequence of the very peculiar pattern of adiposity development in children born SGA during the fetal and postnatal life. However, we failed to observe any significant effect of adiposity at birth or catch-up growth in adiposity on adiponectin levels in the young adults born SGA included in the present study in contrast to the significant association observed with insulin-resistance indices. Thus, although catch-up seems to worsen the consequences of reduced fetal growth on adiponectin production during childhood, this effect disappears once postnatal growth is achieved, whereas the deleterious effect of catch-up growth in adiposity on insulin sensitivity still persists in adulthood. The adverse effect of SGA on adiponectin production and/ or regulation provides an additional example of the consequences of reduced fetal growth on hormonal functions of the adipose tissue. Indeed, we have previously shown that being born SGA is associated with an abnormal regulation of circulating leptin concentrations during childhood leading to relatively low levels of serum leptin levels in adulthood. 16 These abnormal hormonal functions of the adipose tissue observed in subjects born SGA are of most interest regarding the insulin resistance and metabolic complications known to be associated with SGA. Increasing evidences point to an important role of both leptin and adiponectin on glucose homeostasis. 10, 11, [21] [22] [23] Furthermore, adiponectin has been shown to improve glucose metabolism by increasing insulin sensitivity. 12, 13 It was therefore of great interest to investigate the relationship between insulin-resistance indices and serum adiponectin levels. In the present study, this relationship differed from the AGA to the SGA group. The latest Adiponectin concentrations (quartile) Figure 1 Relationship between serum adiponectin levels and insulinsensitivity in the SGA (n ¼ 486) and AGA (n ¼ 573) groups. Insulin-sensitivity was assessed by the fasting insulin-to-glucose ratio. The two study groups were divided in quartiles of serum adiponectin concentrations, I including subjects with the lowest serum adiponectin levels and IV the subjects with the highest levels. The P-values within each group are given after adjustment for current age, BMI, waist-to-hip ratio, gender, oral contraception, smoking and family history of type 2 diabetes.
Serum adiponectin levels in subjects born SGA D Jaquet et al group showed no significant relationship whereas the AGA group demonstrated the well-described negative correlation between insulin-resistance indices and serum adiponectin levels. 10, 11 Moreover, the U-shape relationship observed in the SGA group indicates that some subjects born SGA are insulin resistant despite relatively high levels of adiponectin. This suggests that, in some cases of SGA, whereas the regulatory system of adiponectin and more specifically the stimulatory effect of insulin seems appropriate, the action of the adiponectin on insulin sensitivity is ineffective. One explanation might be searched in the proportion of circulating active adiponectin levels that are undistinguishable by the specific radio-immunoassay used in the present study. Moreover, adiponectin gene undergoes a series of postranslational modification and in fine the action of adiponectin results from the combination of the proportion of active globular and full-length forms of adiponectin that have different affinity for the two adiponectin receptors. 24, 25 A more profound analysis of the adiponectin pathway at the molecular level would be therefore of great interest to understand the defect in insulin-sensitizing action observed in subjects born SGA. In summary, subjects born SGA demonstrated significantly reduced serum adiponectin levels in comparison to agematched controls born AGA. Moreover, no significant relationship was observed between insulin-resistance indices and serum adiponectin levels in these subjects. Although the defect in adiponectin production and in its insulin-sensitizing action evidenced in subjects born SGA remains to be elucidated at the molecular level, these abnormalities strengthen the critical contribution of the adipose tissue in the metabolic complications associated with reduced fetal growth.
